FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to neuropharmacology and psychopharmacology. Disclosed is the use of a PKA inhibitor selected from H 89 dihydrochloride, KT 5720 and PK1 14-22 amide, myristoylated, by subcutaneous administration as a corrector of mnestic disorders caused by senile dementia or cholinergic disorders.
EFFECT: use of the invention enables to effectively treat mnestic disorders caused by senile dementia or cholinergic disorders.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR CORRECTION OF CHOLINERGIC DISORDERS OF THE MNESTIC PROCESSES | 2017 |
|
RU2665970C1 |
| ACTIVE INGREDIENT OF MEDICINAL AGENT WITH CEREBROPROTECTIVE, ANTIHYPOXIC AND ANTIAMNESTIC ACTIVITY FOR TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND METHOD FOR PREPARING THE SAME | 2023 |
|
RU2821508C1 |
| METHOD FOR TREATING AFFECTED AMNESTIC FUNCTIONS | 2004 |
|
RU2268726C2 |
| PHARMACEUTICALLY ACCEPTABLE ACETYL-(D-LYS)-LYS-ARG-ARG-AMIDE PEPTIDE SALTS | 2021 |
|
RU2763136C1 |
| AGENT SHOWING PROPERTIES OF COGNITIVE FUNCTION ACTIVATOR (VERSIONS) | 2010 |
|
RU2438672C1 |
| METHOD OF CORRECTING INTELLECTUAL-MNESTIC FUNCTIONS IN INFANTS SUFFERING FROM RETARDED PSYCHIC DEVELOPMENT | 1991 |
|
RU2020938C1 |
| PREPARATION FOR PREVENTING AND CORRECTING AGE-INDUCED DISORDERS OF HIGHER NERVOUS ACTIVITY | 2005 |
|
RU2296573C2 |
| SUBSTITUTED 3-ARYLSULFONYL-PYRAZOLO[1,5-a]PYRIMIDINE-2,6-DIAMINES, SEROTONIN 5-HT RECEPTOR ANTAGONISTS, METHODS OF PRODUCING AND USING SAID COMPOUNDS | 2010 |
|
RU2421456C1 |
| COMBINATION FOR TREATING AND PREVENTING BEHAVIOURAL, MENTAL, COGNITIVE AND NEUROLOGICAL DISORDERS ACCOMPANYING ORGANIC CNS DISEASES | 2012 |
|
RU2493838C1 |
| LIGAND WITH WIDE RANGE OF SIMULTANEOUS RECEPTOR ACTIVITY, PHARMACEUTICAL COMPOSITION, METHOD OF PREPARING SAID COMPOSITION AND MEDICINAL AGENT | 2008 |
|
RU2374245C1 |
